A detailed history of North Rock Partners, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, North Rock Partners, LLC holds 4,854 shares of TECH stock, worth $357,982. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,854
Previous 8,127 40.27%
Holding current value
$357,982
Previous $582,000 33.51%
% of portfolio
0.03%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$70.96 - $82.35 $232,252 - $269,531
-3,273 Reduced 40.27%
4,854 $387,000
Q2 2024

Aug 06, 2024

BUY
$62.12 - $84.15 $16,461 - $22,299
265 Added 3.37%
8,127 $582,000
Q1 2024

May 07, 2024

BUY
$65.98 - $77.09 $212,323 - $248,075
3,218 Added 69.29%
7,862 $553,000
Q4 2023

Feb 08, 2024

BUY
$52.83 - $78.22 $58,165 - $86,120
1,101 Added 31.08%
4,644 $358,000
Q3 2023

Oct 24, 2023

SELL
$67.52 - $89.42 $45,035 - $59,643
-667 Reduced 15.84%
3,543 $241,000
Q2 2023

Aug 02, 2023

SELL
$73.76 - $85.98 $13,055 - $15,218
-177 Reduced 4.03%
4,210 $343,000
Q1 2023

May 03, 2023

BUY
$71.62 - $86.62 $5,872 - $7,102
82 Added 1.9%
4,387 $325,000
Q4 2022

Feb 01, 2023

BUY
$80.67 - $352.29 $277,343 - $1.21 Million
3,438 Added 396.54%
4,305 $356,000
Q3 2022

Nov 02, 2022

BUY
$282.54 - $391.85 $5,368 - $7,445
19 Added 2.24%
867 $246,000
Q2 2022

Aug 04, 2022

SELL
$322.67 - $449.65 $63,243 - $88,131
-196 Reduced 18.77%
848 $294,000
Q1 2022

May 05, 2022

BUY
$353.85 - $487.79 $77,493 - $106,826
219 Added 26.55%
1,044 $452,000
Q4 2021

Feb 07, 2022

BUY
$456.15 - $525.06 $376,323 - $433,174
825 New
825 $427,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.89B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.